ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 169 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $829,000 | +7.1% | 132,600 | 0.0% | 0.12% | +13.5% |
| Q3 2015 | $774,000 | -29.4% | 132,600 | 0.0% | 0.10% | -11.9% |
| Q2 2015 | $1,097,000 | -4.6% | 132,600 | -5.0% | 0.12% | +0.9% |
| Q1 2015 | $1,150,000 | +16.2% | 139,600 | -3.1% | 0.12% | +15.8% |
| Q4 2014 | $990,000 | +27.2% | 144,100 | 0.0% | 0.10% | +27.8% |
| Q3 2014 | $778,000 | -28.0% | 144,100 | -15.0% | 0.08% | -25.5% |
| Q2 2014 | $1,080,000 | -12.0% | 169,500 | +11.3% | 0.11% | -16.5% |
| Q1 2014 | $1,227,000 | +19.9% | 152,250 | +1.5% | 0.13% | +14.4% |
| Q4 2013 | $1,023,000 | – | 150,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
| Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
| Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
| Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
| Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
| Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
| Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
| PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
| HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |